Bellerophon Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2022.
  • Bellerophon Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $109K, a 132% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $135K, a 2600% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $5K.
  • Bellerophon Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$250K, a 163% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $135K +$130K +2600% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $5K +$255K Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$250K -$647K -163% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $397K +$19K +5.03% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 $378K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.